Development of Nanoparticle-Encapsulated Chemo/Radio-Sensitizers for Intrathecal Delivery |
Yale School of Medicine / Ranjit S. Bindra, MD/PhD & Mark Saltzman, PhD |
Innovation Grants |
2017 |
Connecticut |
Development of Mithramycin Analogs for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD/PhD |
Innovation Grants |
2017 |
Michigan |
Development and Characterization of Novel Models of Human Osteosarcoma Development and Metastasis |
University of Minnesota / Beau Webber, PhD |
Young Investigator Grants |
2017 |
Minnesota |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children’s Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |
De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor |
Feinstein Institute for Medical Research - North Shore / Marc Symons, PhD |
Innovation Grants |
2017 |
New York |
Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas |
University of Manitoba / Tamra Werbowetski-Ogilvie, PhD |
Innovation Grants |
2017 |
Manitoba |
Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors |
Jewish General Hospital / Bárbara Rivera, PhD |
Young Investigator Grants |
2017 |
Quebec |
Anthracycline-Induced Cardiac Toxicity in Pediatric Acute Myeloid Leukemia |
University of Pennsylvania / Kelly Getz, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2017 |
Pennsylvania |
A Home Physical Activity Program to Improve Cognitive Late Effects in Children Treated with Radiation for Brain Tumors |
National Cancer Institute / Pamela Wolters, PhD |
Psychosocial Family Impact Grant |
2017 |
Maryland |